ETFS Holding Theravance, Inc.

 
ETFS Holding Theravance, Inc. top ^
  • Holdings: Top Holdings XBI More..., NPS Pharmaceuticals Inc, Aegerion Pharmaceuticals, Inc., Theravance, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for xbi investment picks

 
Stock Quotes for Theravance, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Distressed
Sign-up for thrx investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Distressed
Sign-up for thrx investment picks

 
News Articles for Theravance, Inc. top ^
2013/3/11
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://media.marketwire.com/attachments/201303/58292_Clinigenlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=995032&ProfileId=051205&sourceType=1 BURTON-ON-TRENT, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA --
Sign-up for Clinigen and Theravance Announce Exclusive Commercialization Agreement in the EU for VIBATIV(R) (telavancin) investment picks
2013/1/31
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980694&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the Leerink Swann Global Healthcare Conference 2013 investment picks
2013/2/13
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=985170&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the 2013 Citi Global Healthcare Conference investment picks
2013/1/29
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979604&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report Fourth Quarter and Full Year 2012 Financial Results on February 12, 2013 investment picks
2013/2/21
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=988474&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at Investor Conferences in March 2013 investment picks
2013/4/11
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1006375&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report First Quarter 2013 Financial Results on April 25, 2013 investment picks
2013/4/17
-- FDA advisory panel backs GSK, Theravance lung drug Breo Ellipta --Some panel members concerned about product safety --
Sign-up for UPDATE: FDA Panel Backs Approval Of Glaxo, Theravance Lung Drug investment picks
2013/4/17
WASHINGTON --A federal advisory panel said Wednesday a proposed lung drug from GlaxoSmithKline PLC (GSK, GSK.LN) was safe and effective at treating chronic obstructive pulmonary disease, or COPD.
Sign-up for FDA Panel: Glaxo, Theravance Lung Drug Is Effective, Safe investment picks
2013/4/17
Theravance Inc. (THRX) said Nasdaq halted trading in its stock ahead of U.S. regulators' scheduled review of the new drug application for Breo Ellipta, a once-daily inhaled drug designed to treat chronic obstructive pulmonary disease, or COPD.
Sign-up for Nasdaq Halts Theravance Ahead of FDA Panel Meeting on COPD Drug investment picks
2013/4/17
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1007992&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Trading in Theravance Common Stock Halted investment picks
2013/4/15
(Updates with GlaxoSmithKline comment in third paragraph and adds additional background) - FDA panel to review GSK, Theravance drug Breo on Wednesday - FDA says safety profile similar to two other COPD products -The company said a once-daily product should boost the number of people who remember to use the COPD medicine.
Sign-up for UPDATE: Glaxo, Theravance Lung Drug Breo Ellipta Face FDA Panel Wednesday investment picks
2013/4/18
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1008400&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Webcast 2013 Annual Meeting of Stockholders on April 24, 2013 investment picks
2013/4/23
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1009760&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at Investor Conferences in May 2013 investment picks
2013/4/22
http://media.marketwire.com/attachments/201212/55322_gsklogo.jpg http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1009287&ProfileId=051205&sourceType=1 LONDON and SOUTH SAN FRANCISCO, CA --
Sign-up for GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan investment picks
2013/4/25
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010859&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Reports First Quarter 2013 Financial Results investment picks
2013/4/25
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010911&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Announces Plan to Separate Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations investment picks
2013/5/10
LONDON --
Sign-up for GSK, Theravance See Breo Ellipta Available in 3Q13 After FDA Approval investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Theravance, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding the Hershey Company  |  Next: ETFS Holding Thor Industries, Inc.